Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

BioNTech Stock News

BNTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$104.40

-0.57-0.54%

At close: -

$104.51

0.110.11%

After Hours: 5:46 PM EDT

CureVac (CVAC) announced it will be acquired by BioNTech (BNTX) on Thursday, June 12, 2025 for $1.25B paid in stock

BioNTech (BNTX) Forecast

News

Earnings BioNTech (BNTX) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest BioNTech Stock News | NASDAQ:BNTX | Benzinga

Get the latest news on BioNTech stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on BioNTech performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, June 18, 2025

'RFK Jr. Weighs Review of Dozens of Shots, Ci...
Benzinga Newsdesk
'Vinay Prasad Named Chief Medical And Science...
Benzinga Newsdesk

Monday, June 16, 2025

5 Stocks To Ride The German Market Rally
Benzinga Research Team
Accenture To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on BioNTech...
Benzinga Newsdesk

Thursday, June 12, 2025

BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal
Vandana Singh
BioNTech Agrees To Acquire CureVac In All-sto...
Benzinga Newsdesk

Tuesday, June 10, 2025

Robert Kennedy Jr Axes Entire CDC Vaccine Panel To 'Restore Public Trust' — Pfizer, Moderna, Other Biotech Stocks Drop In After-Hours Trading
Vishaal Sanjay

Thursday, June 05, 2025

Micron To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on BioNTech...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on BioNTech...
Benzinga Newsdesk

Tuesday, June 03, 2025

US Health Secretary Kennedy Posts On X "I wan...
Benzinga Newsdesk
12 Analysts Have This To Say About BioNTech
Benzinga Insights
Truist Securities Reiterates Buy on BioNTech,...
Benzinga Newsdesk
Why Credo Technology Group Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Avi Kapoor

Monday, June 02, 2025

BioNTech shares are trading higher after the ...
Benzinga Newsdesk
Bristol Myers Inks $11 Billion Licensing Pact With BioNTech For Bispecific Cancer Drug
Vandana Singh
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
BioNTech And Bristol Myers Squibb Partner To ...
Benzinga Newsdesk

Friday, May 30, 2025

'Contradicting RFK Jr., CDC keeps recommendin...
Benzinga Newsdesk

Thursday, May 29, 2025

Goldman Sachs Initiates Coverage On BioNTech ...
Benzinga Newsdesk

Tuesday, May 27, 2025

'New COVID strain from China that led to mass...
Benzinga Newsdesk
Robert F. Kennedy Jr. Says CDC Drops COVID Vaccine For 'Healthy' Pregnant Women, Children
Vandana Singh
US Health Secretary Kennedy Posts On X "Today...
Benzinga Newsdesk
BioNTech To Present Oncology Portfolio At 202...
Benzinga Newsdesk

Thursday, May 22, 2025

'All FDA Committee Members Voted Unanimously ...
Benzinga Newsdesk
JP Morgan Maintains Neutral on BioNTech, Lowe...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on BioNTec...
Benzinga Newsdesk

Wednesday, May 21, 2025

'What's Inside RFK Jr.'s MAHA Report'- Wall S...
Benzinga Newsdesk
FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr.
Tanya Rawat

Tuesday, May 20, 2025

What's Going On With Vaccine Stocks Today?
Vaishali Prayag
FDA's Vinayak Prasad Says No High-Quality Evi...
Benzinga Newsdesk
Shares of vaccine stocks are trading higher f...
Benzinga Newsdesk
'US FDA Advisers To Consider If New COVID Sho...
Benzinga Newsdesk
'FDA Sets New COVID Booster Guidelines Requir...
Benzinga Newsdesk
BioNTech Expands Partnership With The United ...
Benzinga Newsdesk

Monday, May 19, 2025

Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment
Akanksha Bakshi
Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety Scrutiny
Tanya Rawat

Wednesday, May 14, 2025

Where BioNTech Stands With Analysts
Benzinga Insights
HC Wainwright & Co. Maintains Buy on BioNTech...
Benzinga Newsdesk

Sunday, May 11, 2025

Eli Lilly, Affirm And Regeneron Are Among Top 12 Large-Cap Losers Last Week (May 5-May 9): Are The Others In Your Portfolio?
Lekha Gupta

Tuesday, May 06, 2025

Citigroup Maintains Buy on BioNTech, Lowers P...
Benzinga Newsdesk
Morgan Stanley Maintains Overweight on BioNTe...
Benzinga Newsdesk

Monday, May 05, 2025

BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion
Vandana Singh
'Trump To Sign Order To Encourage Domestic Dr...
Benzinga Newsdesk
BioNTech Lowers FY2025 Sales Guidance from $1...
Benzinga Newsdesk
BioNTech Q1 EPS $(1.82) Beats $(2.02) Estimat...
Benzinga Newsdesk
BioNTech Has Appointed Ramón Zapata-Gomez As ...
Benzinga Newsdesk
Earnings Scheduled For May 5, 2025
Benzinga Insights

Tuesday, April 29, 2025

Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline
Tanya Rawat

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved